Ultomiris Drug Market: Growth Opportunities, Trends, and Future Outlook The global pharmaceutical industry has been witnessing a surge in innovative treatments for rare diseases, with biologics and specialty drugs leading the transformation. Among them, Ultomiris (ravulizumab-cwvz), developed by Alexion Pharmaceuticals (now part of AstraZeneca), has emerged as a game-changing...